In this special episode of This Week in Global Development, we explore breast cancer not just as a health challenge, but as a critical development challenge. In low- and middle-income countries, or LMICs, a breast cancer diagnosis can have a devastating ripple effect that extends far beyond the clinic, impacting households, communities, and entire systems. 

Hosted in partnership with The Pfizer Foundation, Devex Executive Vice President and Executive Editor Kate Warren speaks with Darren Back, Dr. Loice Sitienei, and Dr. Patrick Loehrer to explore why integrated breast cancer care strengthens both health systems and economic resilience, ultimately improving outcomes for women facing this disease.

The conversation underscores the systemic barriers to breast cancer care in LMICs, where limited infrastructure and high costs often lead to delays in diagnosis. The Pfizer Foundation's Action and Impact initiative, a philanthropic investment now totaling $25 million across five sub-Saharan African countries, aims to expand access to timely breast cancer diagnosis, treatment, and care. By supporting partners working with local and national governments to advance access to care, the initiative seeks to not only improve breast cancer outcomes but also strengthen overall health systems and long-term prosperity.

To hear more, listen to this on This Week in Global Development.

The Pfizer Foundation is a charitable organization established by Pfizer Inc. and is a separate legal entity with distinct legal restrictions. To learn more about The Pfizer Foundation, click here.